PERSONAL CFO SOLUTIONS, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
PERSONAL CFO SOLUTIONS, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$266,919
-12.8%
12,808
+0.2%
0.05%
-14.5%
Q2 2023$306,105
+26.5%
12,781
-0.6%
0.06%
+24.0%
Q1 2023$242,025
+18.3%
12,860
+0.1%
0.05%
+16.3%
Q4 2022$204,508
-23.4%
12,846
-21.4%
0.04%
-35.8%
Q3 2022$267,000
+16.1%
16,3460.0%0.07%
+24.1%
Q2 2022$230,000
-40.1%
16,346
+3.2%
0.05%
-28.9%
Q1 2022$384,000
+10.7%
15,846
+6.7%
0.08%
+16.9%
Q4 2021$347,000
-25.4%
14,846
-47.0%
0.06%
-31.6%
Q3 2021$465,000
-24.4%
28,000
+11.1%
0.10%
-24.6%
Q2 2021$615,000
-5.4%
25,2000.0%0.13%
-10.6%
Q1 2021$650,000
-44.2%
25,200
+15.6%
0.14%
-51.0%
Q4 2020$1,165,000
+116400.0%
21,8000.0%0.29%
-13.5%
Q3 2020$1,000
-99.9%
21,800
+4.8%
0.33%
+11.7%
Q2 2020$1,008,000
+34.8%
20,800
+17.5%
0.30%
+10.8%
Q1 2020$748,000
+82.0%
17,700
+84.4%
0.27%
+128.0%
Q4 2019$411,0009,6000.12%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders